|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
University of Mississippi Medical Center Office of Minority Health Mississippi Institute for Improvement of Geographic Minority Health |
|---|---|
| Information provided by: | University of Mississippi Medical Center |
| ClinicalTrials.gov Identifier: | NCT00653809 |
Purpose
The goal of this study is to examine the activation of markers of endothelial and cardiovascular dysfunctions, from women with high-risk pregnancies. Information from this study will hopefully provide enough information to determine a link between race, the advent of high risk pregnancies and cardiovascular markers. With this information it might be possible to intervene with approved pharmacological treatments.
| Condition |
|---|
|
Preeclampsia |
| Study Type: | Observational |
| Study Design: | Case Control, Cross-Sectional |
| Official Title: | Elucidating the Role of Nitric Oxide and Endothelin-1 Activation in Endothelial Cells co-Cultured With Placental Explants From African-American and Caucasian High Risk Pregnancies |
Placental Tissue
| Estimated Enrollment: | 45 |
| Study Start Date: | June 2007 |
| Estimated Study Completion Date: | March 2009 |
| Estimated Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
A, 1, I
Caucasian women without preeclampsia or PIH, delivering their first child
|
|
A, 1, II
Caucasian women with preeclampsia or PIH, delivering their first child
|
|
A, 2, I
African-american women without preeclampsia or PIH, delivering their first child
|
|
A, 2, II
African-American women with preeclampsia or PIH, delivering their first child
|
|
B, 1, I
Caucasian women without preeclampsia or PIH, delivering at least their second child
|
|
B, 1, II
Caucasian women with preeclampsia or PIH, delivering at least their second child
|
|
B, 2, I
African-american women without preeclampsia or PIH, delivering at least their second child
|
|
B, 2, II
African-american women with preeclampsia or PIH, delivering at least their second child
|
Eligibility| Ages Eligible for Study: | 18 Years to 40 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Women delivering babies at the University of MS Medical Center
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Kedra L Wallace, MS | 601-984-5311 | kwallace2@pharmacology.umsmed.edu |
| Contact: William A Bennett, PhD | 601-984-5301 | wbennett@ob-gyn.umsmed.edu |
| United States, Mississippi | |
| University of MS Medical Center | Recruiting |
| Jackson, Mississippi, United States, 39216 | |
| Contact: Kedra L Wallace, MS 601-984-5311 kwallace2@pharmacology.umsmed.edu | |
| Contact: William A Bennett, PhD 601-984-5301 wbennett@ob-gyn.umsmed.edu | |
| Principal Investigator: Kedra L Wallace, MS | |
| Principal Investigator: | Kedra L Wallace, MS | Obstetrics & Gynecology |
More Information
| Responsible Party: | University of MS Medical Center ( Kedra Walllace/Researcher IV ) |
| Study ID Numbers: | 2007-0065-MIGMH |
| Study First Received: | April 1, 2008 |
| Last Updated: | November 12, 2008 |
| ClinicalTrials.gov Identifier: | NCT00653809 |
| Health Authority: | United States: Institutional Review Board |
|
Nitric Oxide Hypertension, Pregnancy-Induced Pregnancy Complications Eclampsia |
Pregnancy toxemia /hypertension Pre-Eclampsia Preeclampsia Hypertension |
|
Respiratory System Agents Vasodilator Agents Neurotransmitter Agents Antioxidants Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Anti-Asthmatic Agents Cardiovascular Agents |
Protective Agents Pharmacologic Actions Autonomic Agents Therapeutic Uses Free Radical Scavengers Endothelium-Dependent Relaxing Factors Peripheral Nervous System Agents Bronchodilator Agents |
